Izabela Tworowska Ph.D., M.S.Pharm.
Chief Science Officer at RadioMedix Inc., a biotech company awarded $ 2.8M grant from TETF funds. Her research concentrates on design of multimodality imaging probes targeting cancer cells. Special focus of her work is synthesis and evaluation of radiolab
TETF funds, radiolabeled hedgehog, PET, Ga68, RadioMedix, ACS, JBPC, IUPAC award, Rice University, aacr2010 press release
Is this your site? Certify your site and update informations
